The NHS will provide the monoclonal antibody Crysvita at 20 specialist centres across England for patients with XLH.

It is already used as a recurring treatment for severe asthma in low doses. However, the trial found that a single higher ...

Scientists discover benralizumab could tackle suffocating attacks for people with both asthma and chronic obstructive ...

Discover how ADCs are advancing oncology, the regulatory challenges they face, and the promise they hold for the future of ...

Monoclonal antibodies like cetuximab bind to proteins on the surface of cancer cells ... The results have significant ...

An injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, ...

Benralizumab is a monoclonal antibody that targets specific white blood cells, called eosinophils, to reduce lung ...

London scientists have created a “game-changing” new treatment for asthma attacks that can reduce the need for further ...

More than five million people in the UK suffer from asthma, but a new drug called benralizumab could change the game.

An injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, ...

A decade after the discovery of CALR, the results are the first for a possible therapy for CALR-mutated MPNs to reach the ...